Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 34Leiomyoma 12Menorrhagia 5Endometriosis 4Myofibroma 3Prostate Adenocarcinoma 2Pregnancy Complications 2Adenocarcinoma 2Uterine Neoplasms 1Uterine Hemorrhage 1Pathologic Complete Response 1Neoplasm, Residual 1Neoplasm Metastasis 1Myoma 1Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1Metastatic Castration-Resistant Prostate Cancer 1Hormone Treatment-naïve Participants With Prostate Cancer 1

Interventions

relugolix 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hormone Treatment-naïve Participants With Prostate Cancer × relugolix × Clear all
NCT02141659 2018-11-19

A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer

Takeda

Phase 1 Completed
43 enrolled 23 charts
Genitourinary

Hormone Treatment-naïve Participants With Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡